[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Tue, Jun 14th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Mon, Jun 13th 2022 ]: WOPRAI
[ Sun, Jun 12th 2022 ]: WOPRAI
[ Sun, Jun 12th 2022 ]: WOPRAI
[ Sun, Jun 12th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
[ Fri, Jun 10th 2022 ]: WOPRAI
Bill Sutherland Maintained (CCRN) at Strong Buy with Decreased Target to $37 on, Jun 13th, 2022
- 🞛 This publication is a summary or evaluation of another publication
Bill Sutherland of Benchmark, Maintained "Cross Country Healthcare, Inc." (CCRN) at Strong Buy with Decreased Target from $42 to $37 on, Jun 13th, 2022.
Bill has made no other calls on CCRN in the last 4 months.
There is 1 other peer that has a rating on CCRN. Out of the 1 peers that are also analyzing CCRN, all agrees with Bill's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Nick Giovacchini of "Credit Suisse" Maintained at Hold with Decreased Target to $26 on, Thursday, June 9th, 2022